Previously submitted to: Journal of Medical Internet Research (no longer under consideration since Apr 14, 2025)
Date Submitted: Jul 31, 2024
Open Peer Review Period: Aug 7, 2024 - Oct 2, 2024
(closed for review but you can still tweet)
NOTE: This is an unreviewed Preprint
Warning: This is a unreviewed preprint (What is a preprint?). Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn (a note "no longer under consideration" will appear above).
Peer review me: Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period (in this case, a "Peer Review Me" button to sign up as reviewer is displayed above). All preprints currently open for review are listed here. Outside of the formal open peer-review period we encourage you to tweet about the preprint.
Citation: Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author).
Final version: If our system detects a final peer-reviewed "version of record" (VoR) published in any journal, a link to that VoR will appear below. Readers are then encourage to cite the VoR instead of this preprint.
Settings: If you are the author, you can login and change the preprint display settings, but the preprint URL/DOI is supposed to be stable and citable, so it should not be removed once posted.
Submit: To post your own preprint, simply submit to any JMIR journal, and choose the appropriate settings to expose your submitted version as preprint.
Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
The Development of Telepathology in China and the Perceptions of Pathologists and Patients: National Cross-Sectional Survey
ABSTRACT
Background:
Telepathology has proven to be a viable solution to provide timely, high-quality diagnostic services to underserviced, remote areas, and is widely applied in the word. The government strongly supports the development of telepathology to alleviate the shortage of pathologists in China. This study aimed to survey telepathology in China, and analyze the usage and attitudes of both pathologists and patient.
Objective:
This study aims to analyze the construction, application, and development of telepathology in China from 2018 to 2023, understand the usage, evaluation, and attitudes of pathologists and patients towards telepathology, and analyze the existing problems and improvement suggestions in the application of telepathology.
Methods:
A national survey was administered to Chinese hospitals in 2018, 2019, 2020 and 2023. A survey to doctors and patients who participated in telemedicine services was conducted in 2019. Based on this data, we analyze telepathology in China. Chi-square test and Fisher's exact probability test were used to test the difference among different years, different levels of hospitals, and different regions.
Results:
The annual average growth rate of the proportion of telepathology software in the surveyed hospitals was 7.60%, from 29.53% in 2018 to 42.55% in 2023. From 2018 to 2023, the number of telepathology service cases in China has been continuously increasing, with the median number per hospital growing from 51 to 200 cases, and the fastest growth was in the eastern region. Once a week was the dominant frequency(63.64%) among pathologists in China. The average time for participating in telepathology services was mainly 11-20 min and 21-30min. The pathologists' overall satisfaction rate was 99.35%, and the most frequently mentioned difficulties were unreasonable scheduling, small coverage, inadequate publicity, and network problems. 92.20% of the patients received their diagnostic results within 24 hours, all patients were satisfied with telepathology, and 99.29% of them were willing to recommend it to other patients.
Conclusions:
The construction and application of telepathology in China have achieved significant growth from 2018 to 2023. Despite some existing barriers with its application, both pathologists and patients exhibit high satisfaction with telepathology. Unreasonable scheduling, limited coverage, inadequate publicity, and network issues are the main problems affecting telepathology. Recommendations include expanding service methods, shortening wait times, strengthening publicity, incorporating telepathology fees into medical insurance, and enhancing training for primary healthcare personnel.
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.